By Tom Zanki ( June 21, 2017, 5:25 PM EDT) -- Avexis Inc., a biotech company developing treatments for rare genetic diseases, on Tuesday priced a $235 million follow-on offering to fund research and manufacturing activities, while Loxo Oncology Inc. closed a $261 million offering, the latest signs of health in the follow-on market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.